ACC 2010 schedule: Difference between revisions
Jump to navigation
Jump to search
| (One intermediate revision by the same user not shown) | |||
| Line 77: | Line 77: | ||
=== <font color="green">11:30 AM</font>=== | === <font color="green">11:30 AM</font>=== | ||
*'''Presenter:''' Freek.W.A. Verheugt | *'''Presenter:''' Freek.W.A. Verheugt | ||
=== <font color="green">12:00 PM</font>=== | === <font color="green">12:00 PM</font>=== | ||
| Line 158: | Line 157: | ||
=== <font color="green">1:00 PM</font>=== | === <font color="green">1:00 PM</font>=== | ||
*'''Interviewer:''': Bimal Shah | |||
=== <font color="green">1:30 PM</font>=== | === <font color="green">1:30 PM</font>=== | ||
Latest revision as of 20:31, 14 March 2010
Here is the page we will use to coordinate interviews at ACC 2010
Filming location: Atlanta Marriott Downtown 160 Spring Street Atlanta, GA 30303
Filming will occur from Saturday to Tuesday (March 13 - March 16). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.
Click on Date for Detailed Schedule
Saturday, March 13, 2010
9:00 AM
9:30 AM
10:15 AM
- Interviewee: Robert M. Califf
- Trial: The Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research (NAVIGATOR) Trial
11:00 AM
- Interviewee: Manesh R. Patel
11:30 AM
12:00 PM
12:30 PM
1:00 PM
1:30 PM
2:00 PM
2:30 PM
3:00 PM
3:30 PM
4:00 PM
4:30 PM
- Interviewee: Hyo-Soo Kim
- Trial: Randomized Trial Evaluating the Efficacy of Cilostazol on Ischemic Vascular Complications after Drug-eluting Stent Implantation for Coronary Heart Disease: Influence of Cilostazol-based triple anti-platelet therapy on Ischemic Complication after drug-eluting stent implantation (CILON-T) study
Sunday March 14, 2010
8:30 AM
9:00 AM
9:30 AM
10:00 AM
10:30 AM
11:00 AM
- Presenter: Mark Chan
- Presentation: Temporal Trends Over 15 Years in Clinical Trials of Non-ST Elevation Acute Coronary Syndromes: More Aggressive Treatment Yields Similar Mortality Despite Higher-Risk Profiles
11:30 AM
- Presenter: Freek.W.A. Verheugt
12:00 PM
12:30 PM
- Interviewee: Tracy Y. Wang
- Presentation: Upfront Clopidogrel Use and the Efficacy and Safety of Early Eptifibatide Use in Patients with Acute Coronary Syndrome: An Analysis from the Early versus Delayed Provisional Eptifibatide in Acute Coronary Syndromes (EARLY ACS) trial
1:00 PM
- Interviewee: Chiara Melloni
- Presentation: Safety and Efficacy of Adjusted-Dose Eptifibatide in Patients with Acute Coronary Syndromes and Reduced Renal Function
1:30 PM
- Interviewee:
- Trial:
2:00 PM
- Interviewee: Francois Schiele
- Trial: Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis
2:30 PM
- Interviewee: Michael Maeng
- Trial: Randomized All-comer Comparison of Zotarolimus-eluting and Sirolimus-eluting Coronary Stents: 18-month Follow-up in the SORT OUT III Trial
3:00 PM
- Interviewee: Michael D. Ezekowitz
- Trial: A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation
3:30 PM
- Interviewee: Gary Michael Felker
- Trial: The Diuretic Optimization Strategies Evaluation (DOSE) Study: A Randomized, Double Blind, Placebo-controlled Trial Of Diuretic Strategies In Acute Decompensated Heart Failure
4:00 PM
- Interviewee: George H. Crossley, III
- Trial: The Impact of Remote Monitoring with Automatic Clinician Notifications on the clinical care of ICD and CRT-D Patients
4:30 PM
5:00 PM
- Interviewee: Henry Ginsberg
- Trial: Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study
Monday March 15, 2010
8:00 AM
- Interviewee: Rhonda M. Cooper-Dehoff
- Trial: Rethinking Lower BP Goals for Diabetics with Documented Coronary Artery Disease: Findings from the INternational VErapamil SR - Trandolapril STudy (INVEST)
8:30 AM
- Interviewee: Peter Clemmensen
- Trial: Long-term Outcome after Drug-Eluting versus Bare-Metal Stent Implantation in Patients with ST-Elevation Myocardial Infarction. Three-year follow-up of the DEDICATION Trial
9:00 AM
- Interviewee: Robert A. Byrne
- Trial: Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes
9:30 AM
- Interviewee: Steven Goldman
- Trial: A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study
10:00 AM
- Interviewee: Ted Feldman
- Trial: Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial
10:20 AM
- Interviewee: Claes Held
- Trial: Ticagrelor Versus Clopidogrel In Patients With Acute Coronary Syndromes Undergoing Coronary Artery Bypass Surgery: Results From The PLATO Trial
11:00 AM
11:30 AM
12:00 PM
12:30 PM
1:00 PM
- Interviewer:: Bimal Shah
1:30 PM
2:15 PM
- Interviewee: William C. Cushman
- Trial: Effects of Intensive Blood Pressure Control on Cardiovascular Events in Type 2 Diabetes Mellitus: The Action to Control Cardiovascular Risk in Diabetes (ACCORD) Blood Pressure Trial
2:30 PM
- Interviewee: Robert S. Epstein
- Trial: Effect of Genotyping Warfarin Patients on Outcomes: Results from the National Community-based Medco-Mayo Warfarin Effectiveness Study (MM-WES)
3:00 PM
3:30 PM
- Interviewee: Hisao Ogawa
4:00 PM
- Interviewee: Hisao Ogawa
- Presentation: Endo-PAT evaluation of Endothelia function
4:30 PM
Tuesday March 16, 2010
8:30 AM
9:00 AM
- Interviewer: Bimal R. Shah
9:30 AM
- Interviewee: David Antoniucci
- Trial: Randomized Comparison of Angiojet Rheolytic Thrombectomy Before Direct Infarct Artery Stenting to Direct Stenting Alone in Patients with Acute Myocardial Infarction: the Jetstent Trial
10:00 AM
- Interviewee:
- Trial: